Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Cabometyx cabozantinib's malate?Prialt ziconotide loss of exclusivity date us?How do generic and branded tigecycline's side effects differ?Patent expiry date of lucentis?Lo loestrin paragraph iv?
See the DrugPatentWatch profile for keytruda
Pembrolizumab (Keytruda) received its first FDA approval in 2014. [1]
The initial FDA approval for pembrolizumab was tied to treatment of certain cancers, marking the start of Keytruda’s FDA approval timeline in 2014. [1] Sources: [1] https://www.drugpatentwatch.com/patent/Keytruda/US-9758418
Other Questions About Keytruda :